U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 19-25, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 19-25, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 02/21/2023
Location: Washington, DC
Subject: Food and Drug Administration Alumni Association Winter Celebration
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Food and Drug Administration Alumni Association attended

Event Date: 02/21/2023
Location: Virtual
Subject: Infant Formula Supply
FDA Participant/Group: JULIA TIERNEY; MARK RAZA; TRISTAN COLONIUS; SUSAN MAYNE;
Non FDA Participant/Group: Hubert Allen, Monica Wilkins, Robert Ford (Abbott Laboratories);

Event Date: 02/21/2023
Location: Virtual
Subject: Announcement of Draft Labeling Guidance for Plant-Based Milk Alternatives
FDA Participant/Group: TRISTAN COLONIUS; SUSAN MAYNE;
Non FDA Participant/Group: Clay Detlefsen, Jim Mulhern (The National Milk Producers Federation);

Event Date: 02/21/2023
Location: Virtual
Subject: Announcement on Draft Labeling Guidance for Plant-Based Milk Alternatives
FDA Participant/Group: TRISTAN COLONIUS; SUSAN MAYNE;
Non FDA Participant/Group: Dustin Cox (National Association of Dairy Regulatory Offices); Stephen Beam (National Conference on Interstate Milk Shipments);

Event Date: 02/21/2023
Location: Virtual
Subject: Announcement on Draft Labeling Guidance for Plant-Based Milk Alternatives
FDA Participant/Group: SUSAN MAYNE; TRISTAN COLONIUS;
Non FDA Participant/Group: Ted McKinney (National Association of State Departments of Agriculture); Doug Miyamoto (Wyoming Department of Agriculture);

Event Date: 02/22/2023
Location: North Bethesda, MD
Subject: Fourth Annual NIH Helping to End Addiction Long-term (HEAL) Initiative Investigator Meeting
FDA Participant/Group: MICHELLE ADAMS;
Non FDA Participant/Group: Government, academia, industry, and other invited guests

Event Date: 02/23/2023
Location: Arlington, VA
Subject: Health Datapalooza
FDA Participant/Group: STEPHANIE CACCOMO; STACY MATHEW;
Non FDA Participant/Group: Government, academia, industry, media, and other registered attendees

Event Date: 02/24/2023
Location: Virtual
Subject: Powdered Infant Formula Safety Strategy
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff from Reckitt

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/21/2023
Location: Virtual
Subject: Retail Food Safety Modernization Webinar
FDA Participant/Group: LAURIE FARMER;
Non FDA Participant/Group: Participants from retail foodservice operations, several FDA staff, industry representatives, and state and local regulators

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 02/22/2023
Location: Karnataka, India
Subject: Areas of Mutual Regulatory Interest and Future Collaborations
FDA Participant/Group: SARAH MCMULLEN, SUNHEENDRA KULKARNI, KAREN RILEY
Non FDA Participant/Group: Sri. Bhagoji T. Khanapure (Karnataka Drugs Control Directorate);

Event Date: 02/22/2023
Location: Karnataka, India
Subject: Areas of Mutual Regulatory Interest and Future Collaborations
FDA Participant/Group: SARAH MCMULLEN, SUNHEENDRA KULKARNI, KAREN RILEY
Non FDA Participant/Group: J. Manjunath (Karnataka (AYUSH) Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 02/23/2023
Location: Virtual
Subject: Single Cell Omics Symposium; Opening Remarks
FDA Participant/Group: NAMANDJE BUMPUS;
Non FDA Participant/Group: Attendees from industry, academia, government, and other stakeholders

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 02/24/2023
Location: Virtual
Subject: National Academies' Workshop on FDA's Accelerated Approval Program
FDA Participant/Group: RENEE ZELLNER; JACQUELINE CORRIGAN CURAY;
Non FDA Participant/Group: Anne-Marie Mazza, Steven Kendall (National Academies); Barbara E. Bierer (Harvard University); William B. Schultz (Zuckerman Spaeder);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/24/2023
Location: Orlando, FL
Subject: We’re Organizing Research on Lysosomal Diseases (WORLD) Symposium; Taking Gene Therapy to the Next Level
FDA Participant/Group: N/A
Non FDA Participant/Group: Basic, translational and clinical researchers, patient advocacy groups, and clinician stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/22/2023
Location: Virtual
Subject: Laboratory Developed Tests
FDA Participant/Group: ELLEN FLANNERY; MCKENNA TENNANT; ELIZABETH HILLEBRENNER; KIMBERLY KOPECKI; ABIGAIL KELLER; TOBY LOWE; TIMOTHY STENZEL; JENNIFER TOMASELLO;
Non FDA Participant/Group: Donald Karcher, Emily Volk, Helena Duncan, John Scott, Jonathan Myles, Stephanie Peditto (College of American Pathologists);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 02/23/2023
Location: Virtual
Subject: Front of Pack (FOP) Labeling
FDA Participant/Group: ROBIN MCKINNON; CONRAD CHOINIERE; MEGAN VELEZ; KARI BARRETT; EMILY ROSE CAREY; WILLIAM HUBBARD;
Non FDA Participant/Group: Hilary S. Thesmar, Jennifer Hatcher, Krystal Register (Food Marketing Institute (FMI));

Event Date: 02/24/2023
Location: Virtual
Subject: Infant Formula Meeting
FDA Participant/Group: LARRY MORRIS; DONALD PRATER; CYNTHIA JOHNSON; JESSICA ROWDEN; JENNIFER DOOREN;
Non FDA Participant/Group: Robert C. Post (Infant Nutrition Council of America (INCA)); Jennifer Hatcher (Food Marketing Institute (FMI)); Joe Scimeca, Michael Dykes (International Dairy Foods Association (IDFA));

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 02/22/2023
Location: Virtual
Subject: Biannual Meeting Planning Session with Global Tobacco Regulators Forum (GTRF) Steering Committee
FDA Participant/Group: MEGAN HICKS;
Non FDA Participant/Group: Several representatives from the Global Tobacco Regulators Forum (GTRF) Steering Committee

Event Date: 02/24/2023
Location: Virtual
Subject: Virtual Live Forum; Programmatic Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from American Vapor Manufacturers

Official Name: Tracey H. Forfa, J.D., Acting Director, Center for Veterinary Medicine

Event Date: 02/23/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: KIRSTEN BYERTS; CINDY BURNSTEEL; JULIANNA WITTIG; AMBER MCCOIG; CHRISTOPHER CAMPBELL; PADMASHRI NALUBOLA; WILLIAM FLYNN; ROSEMARY EARLEY; NADINE STEINBERG; NICHOLAS ALEXANDER; TERESA CROCE; MEGAN HOWARD;
Non FDA Participant/Group: Representatives of the National Association of Boards of Pharmacy (NABP)

Event Date: 02/23/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: JULIANNA WITTIG; MATTHEW LUCIA; ANTONIA MONIQUE SENNETT; ROSEMARY EARLEY;
Non FDA Participant/Group: Representatives of the Generic Animal Drug Alliance (GADA)

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 
Back to Top